Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Pharmacogenet Genomics. 2011 Jan;21(1):1–9. doi: 10.1097/fpc.0b013e328340bc5a

Figure 2.

Figure 2

Percentage of tolerant white non-Hispanic subjects who remitted shown by CYP2C19 activity genotype based category. Bars represent 95% CI. The overall remission rate in the study adherent tolerant white non-Hispanic subjects was 57.8% (405/872).